netFormulary Oxfordshire Clinical Commissioning Group NHS
Formulary  
 Search
 Formulary Chapter 3: Respiratory system - Full Chapter
Chapter Links...
 Details...
03.04.01  Expand sub section  Antihistamines
03.04.01  Expand sub section  Non-sedating antihistamines
Cetirizine
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Brown

Available to purchase over the counter.

Only prescribe if required on a continuous basis for chronic rhinosinusitis and chronic urticaria, in line with Clinical Commissioning Policy 88D

For spontaneous urticaria in line with Management Guideline for Spontaneous Urticaria with/without Angioedema in Adults

 
Loratadine
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Brown

Available to purchase over the counter.

Only prescribe if required on a continuous basis for chronic rhinosinusitis and chronic urticaria, in line with Clinical Commissioning Policy 88D

For spontaneous urticaria in line with Management Guideline for Spontaneous Urticaria with/without Angioedema in Adults

 
Fexofenadine
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Brown

Restricted for use where cetirizine, loratadine and chlorphenamine have been tried or are not suitable. 

APCO July 2014. 

For spontaneous urticaria in line with Management Guideline for Spontaneous Urticaria with/without Angioedema in Adults

 
   
Acrivastine (Benadryl® Allergy Relief)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Brown

Available to purchase over the counter.

Only prescribe if required on a continuous basis for chronic rhinosinusitis and chronic urticaria, in line with Clinical Commissioning Policy 88D

 
   
03.04.01  Expand sub section  Sedating antihistamines
 ....
 Non Formulary Items
Bilastine  (Ilaxten®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Desloratadine  (Neoclarityn®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Levocetirizine  (Xyzal®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Mizolastine  (Mizollen®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Rupatadine  (Rupafin®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

In line with Guideline for Spontaneous Urticaria with/without Angioedema in Adults.

APCO November 2017.

 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Red: Medicines which should only be prescribed in secondary care by a specialist.  

Amber Continuation

Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred.   

Amber Shared Care Protocol

Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO).   

Green

Green: Medicines which are suitable for initiation and ongoing prescribing within primary care.   

Brown

Brown: Medicines which should only be prescribed in restricted circumstances.  

Black

Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.  

OCCG Green

not used  

netFormulary